Zum Inhalt

BMC Cancer

Ausgabe Sonderheft 1/2007 24th Annual Meeting of the National Cancer Institute of Mexico

Inhalt (51 Artikel)

Adriamycin-Cyclophosphamide (AC) followed by Paclitaxel-Cisplatin (PC). A highly active neoadjuvant regimen in locally advanced breast cancer

  • Open Access
  • Meeting abstract

Daniel Mendoza-Posada, Teresa Vela-Chavez, Enrique Bargallo-Rocha, Nestor Villafañe, Carlos Gamboa-Vignole, Claudia Arce

Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation

  • Open Access
  • Meeting abstract

Pilar Nava-Parada, Adam Herron, Keith L Knutson, Larry Pease, Esteban Celis

Surveillance in surgery prevents infections and ensures good quality of care

  • Open Access
  • Meeting abstract

Diana Vilar-Compte, Samuel Rosales Pérez, Inés Álvarez de Iturbe, Eduardo Maafs, Carlos Robles-Vidal, Enrique Bargallo, Ma Cruz Pérez-Amador, Patricia Volkow

Imaging evaluation of phylodes tumor at the National Institute of Cancerology: 86 patient series

  • Open Access
  • Meeting abstract

Nestor Villafañe, Yolanda Villaseñor, Adolfo Fuentes-Alburo, Diana Vilar-Compte

Molecular characterization of BRCA1 and BRCA2 genes in breast cancer patients under 40 years-old or with familiar cancer history

  • Open Access
  • Meeting abstract

Silvia Vidal Millan, Lucia Taja Chayeb, Vanessa Rosas Camargo, Olga Gutierrez Hernandez, Alfonso Dueñas-Gonzalez

Metaplastic carcinoma of the breast: a clinical and pathological study of 40 cases

  • Open Access
  • Meeting abstract

Verónica Arce-Grijalva, Teresa Vela-Chávez, Víctor M Pérez-Sánchez, Eva Ruvalcaba-Limón

Role of HPV18 E6 in PKB signal transduction pathways

  • Open Access
  • Meeting abstract

Adriana Contreras, Imelda Martínez, Erick De la Cruz, Marcela Lizano

MTHFR (C677T) polymorphism determination in patients with metastatic colon cancer and its effect on the treatment with 5-fluorouracil and folinic acid

  • Open Access
  • Meeting abstract

Omar Fernández-Castillo, Aldo Bauza, Germán Calderillo, Clementina Castro, Roberto Herrera, Luis A Herrera

Study of the polymorphism Mad1 G558A in a Mexican population and its relationship with the generation of aneuploidy

  • Open Access
  • Meeting abstract

Miguel Santibáñez, Clementina Castro, Alejandro López, Luis A Herrera

Signaling induced by PAR1 on breast cancer cell lines is correlating with its invasive potential

  • Open Access
  • Meeting abstract

Gisela Ceballos Cancino, Vilma Maldonado Lagunas, Norma A Hernández Rodríguez

Apoptosis induced by cisplatin but not by 5-FU in colon cancer cells depends on Omi/Htra2 protein

  • Open Access
  • Meeting abstract

Franz G Pruefer, Floria Lizárraga-Sánchez, Vilma Maldonado-Lagunas, Jorge Meléndez-Zajgla

Up-regulation of HLA class I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating hydralazine and the histone deacetylase inhibitor valproic acid

  • Open Access
  • Meeting abstract

María de Lourdes Mora-García, Alfonso Duenas-González, Jorge Hernández-Montes, Benny Weiss-Steider, Edelmiro Santiago-Osorio, Vianney Francisco Ortíz-Navarrete, Víctor Hugo Rosales, David Cantú, Marcela Lizano-Soberón, Alberto Monroy-García

Prediction of the recurrence probability in patients with parotid gland cancer

  • Open Access
  • Meeting abstract

Rafael Vazquez-Romo, Jose Carrillo, Roberto Herrera-Goepfert, Ana Cano, Margarita Ramirez-Ortega, Luis F Oñate-Ocaña

Expression of MMPs and TIMPs in different tumor progression stages of oral cavity squamous cells carcinoma (experience of 30 cases in Instituto Nacional de Cancerología, México 1999–2004)

  • Open Access
  • Meeting abstract

Lourdes Suarez-Roa, Abelardo Meneses-Garcia, Enrique Pérez-Cardenas, J Asbun, Luz Maria Ruiz-Godoy

Prevalence of human Papillomavirus in head and neck cancer in Mexico: a case-control study

  • Open Access
  • Meeting abstract

Samantha Carrera-Cáceres, Dulce M Hernández-Hernández, Teresa Apresa, José F Gallegos-Hernández, Miriam Guido-Jiménez, Alejandro García-Carrancá

Outcomes of radiotherapy in patients with glottic larynx cancer T1 and T2

  • Open Access
  • Meeting abstract

Jesús M Flores, Maria A Poitevín, Luis F Oñate

Concurrent chemoradiation with carboplatin for locally advanced cervical cancer at high-risk for developing cisplatin-induced renal dysfunction

  • Open Access
  • Meeting abstract

Lucely Cetina, Alicia Garcia-Arias, Maria de Jesus Uribe, Alma Astorga, Myrna Candelaria, Aida Mota, Roque Guadarrama, Lesbia Rivera, Jose Hinojosa, Alfonso Dueñas-Gonzalez

Synergistic effects of mifepristone on the cytotoxicity of cisplatin in cervical carcinoma cell lines and tumors grown in athymic mice

  • Open Access
  • Meeting abstract

Rafael Jurado, Angélica López-Flores, Aarón Álvarez-Figueroa, Patricia García-López

Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA

  • Open Access
  • Meeting abstract

Lucely Cetina, Alicia Garcia, Jesús Uribe, Myrna Candelaria, Carlos Lopez-Graniel, Aaron Gonzalez, David Cantu, Lesbia Rivera, Jose Hinojosa, Alfonso Dueñas-Gonzalez

Differential expression of HacaT cells transfected with E6 oncogen from the HPV18 Asian-Amerindian and European variants

  • Open Access
  • Meeting abstract

Verónica Fragoso, Marcela Lizano, Erick De la Cruz-Hernandez, Mauricio Salcedo

Expression of viral and cellular cycle proteins and proteinases in cervical carcinoma cell lines as possible immunocytochemical markers of malignant phenotype

  • Open Access
  • Meeting abstract

Salvador Vázquez-Vega, Patricia Sánchez-Suárez, Alejandro García-Carrancá, Luis Benítez-Bribiesca

Frequency and follow-up of cytological studies diagnosed as atypical squamous cell (ASC) at Instituto Nacional de Cancerologia from 2000 to 2004

  • Open Access
  • Meeting abstract

María Verónica Arce-Grijalva, Rita Sotelo-Regil Hallmann, Margarita Ibarra del Río, Carlos Enrique González Carrillo

A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer

  • Open Access
  • Meeting abstract

Claudia Arce, Carlos Perez-Plasencia, Aurora Gonzalez-Fierro, Erik de la Cruz-Hernandez, Alma Revilla-Vazquez, Alma Chavez-Blanco, Catalina Trejo-Becerril, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Enrique Bargallo, Patricia Villarreal, Teresa Ramirez, Teresa Vela, Myrna Candelaria, Maria F Camargo, Elizabeth Robles, Alfonso Dueñas-Gonzalez

Pericentromeric demethylation and chromosomal instability induced by chemicals

  • Open Access
  • Meeting abstract

Diddier Prada, Clementina Castro, Lisandro Sánchez, Roxanna Pérez, Rodrigo González, Luis A Herrera

The effects of DNA methylation and histone deacetylase inhibitors upon the human papillomavirus early genes expression in cervical cancer. An in vitro and clinical study

  • Open Access
  • Meeting abstract

Erik de la Cruz-Hernandez, Adriana Contreras-Paredes, Alejandro Mohar, David Cantú, Marcela Lizano, Alfonso Duenas-Gonzalez

Analysis of the methylation status of HPV DNA in human cell lines

  • Open Access
  • Meeting abstract

Rocio S Méndez, Cristian P Miguez, Miriam C Guido, Alejandro García-Carrancá

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

  • Open Access
  • Meeting abstract

Myrna Candelaria, Dolores Gallardo-Rincón, Claudia Arce, Lucely Cetina, Jose Luis Aguilar-Ponce, Oscar Arrieta, Alberto Serrano, Carlos Perez-Plasencia, Aurora Gonzalez-Fierro, Erik de la Cruz-Hernandez, Alma Revilla-Vazquez, Alma Chavez-Blanco, Catalina Trejo-Becerril, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Maria F Camargo, Elizabeth Robles, Alfonso Dueñas-Gonzalez

Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study

  • Open Access
  • Meeting abstract

Myrna Candelaria, Lucely Cetina, Alicia Garcia, Talia Wegman-Ostrosky, Elizabeth Robles, Aurora González-Fierro, Carlos López-Graniel, Aaron González, David Cantú, Lesbia Ribera, Lucia Taja-Chayeb, Catalina Trejo-Becerril, Enrique Pérez-Cárdenas, Carlos Pérez-Plasencia, Alma Chavez-Blanco, Alfonso Dueñas-González

Lung cancer mortality in Mexico

  • Open Access
  • Meeting abstract

Luz Ma Ruíz-Godoy, Pedro Rizo, Felipe Sánchez, Alvaro Osornio, Claudia García, Abelardo Meneses García

PM10from Mexico City (MC) induce senescence-like phenotype and ATM, γH2A.X and p53 activation linked to oxidative stress

  • Open Access
  • Meeting abstract

Yesennia Sánchez-Pérez, Concepción Gutiérrez-Ruíz, Álvaro Osornio-Vargas, Yazmin Segura, Graciela Yescas, Claudia García-Cuellar

Effect of the all-trans retinoic acid on neural growth factor serum levels (NGF) and chemotherapy induced neuropathy in patients with advanced lung cancer

  • Open Access
  • Meeting abstract

Oscar Arrieta, Tania Cerón, Diana Estrada-Flores, Felipe Sánchez, Graciela Ordoñez, Julio Sotelo

The diagnostic utility of inmunohistochemical and electronic microscopy in distinguishing between pleural mesothelioma and adenocarcinoma

  • Open Access
  • Meeting abstract

Carlos González Carrillo C, Hugo Dominguez Malagón, Oscar Arrieta

Clinical and pathologic factors associated with development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study

  • Open Access
  • Meeting abstract

Vanessa Rosas-Camargo, José Luis Rodríguez-Díaz, Olynka Vega-Vega, Aniela Méndez-Reguera, Daniela Morales Espinosa, Jorge Luis Martínez-Tlahuel, Armando Gamboa-Domínguez, Oscar Arrieta

Magnification endoscopy to detect dysplastic aberrant crypt foci in Mexican patients with high risk for colorectal cancer

  • Open Access
  • Meeting abstract

Fabiola Trejo-Vázquez, Sergio Sobrino-Cossío S, Angelica Hernández-Guerrero, Roberto Herrera-Goepfert, Julio Sánchez-Del Monte, Juan Octavio Alonso-Larraga JO

Prediction of morbidity after gastrectomy for gastric adenocarcinoma using logistic regression analysis

  • Open Access
  • Meeting abstract

Luis F Oñate-Ocaña, Mauricio Becker, Vincenzo Aiello-Crocifoglio, Rocío Brom-Valladares, José F Carrillo, Francisco Ochoa-Carrillo, Arturo Beltrán-Ortega

Adaptation of the questionnaire EORTC QLQ-STO22 to measure quality of life from Mexican patients with gastric carcinoma

  • Open Access
  • Meeting abstract

Luis Oñate, Alberto Alcántara, Salvador Alvarado, Edith Rojas, Vincenzo Aiello, Germán Calderillo

Major complications following exenteration in cases of pelvic malignancy: an 18-year experience

  • Open Access
  • Meeting abstract

Horacio Lopez-Basave, Flavia Morales-Vasquez, Esmeralda Ochoa, Patricia Ochoa, Juan Ruiz-Molina

Pancreatoduodenectomy, fifteen years of experience

  • Open Access
  • Meeting abstract

Juan Ruiz-Molina, Esmeralda Ochoa, Eduardo Hernández-Castillo, Horacio Lopez-Basave

Polymorphisms of the thiopurine methyl transferase gene in healthy and acute lymphoblastic leukemia mestizos

  • Open Access
  • Meeting abstract

Myrna Candelaria, Lucia Taja-Chayeb, Silvia Vidal-Millan, Olga Gutierrez, Patricia Ostrosky-Wegman, Alfonso Duenas-Gonzalez

Survival among AIDS patients with and without non-Hodgkin's lymphoma, and NHL-HIV-negative patients

  • Open Access
  • Meeting abstract

Patricia Cornejo-Juárez, Patricia Volkow-Fernández, Alejandro Avilés-Salas, Ernesto Calderón-Flores

Clonal evolution in a patient with CML detected by FISH precedes imatinib treatment failure

  • Open Access
  • Meeting abstract

Virginia Enriquez, Judith Cruz, Olga Gutierrez, Maria Teresa Salles, Pablo Vargas, Arturo Martínez, Myrna Candelaria, Rafael Hurtado, Eduardo Cervera

Hematopoietic stem cell transplantation in Multiple Myeloma. Experience of the Instituto Nacional de Cancerologia, Mexico

  • Open Access
  • Meeting abstract

Magdalena Bahena-Garcia, Silvia Rivas-Vera, Pedro Sobrevilla-Calvo, Juan Labardini-Mendez, Eduardo Cervera-Ceballos, Ernesto Calderon-Flores

Percutaneous interventional procedures with ultrasonographic guidance in patients with cancer

  • Open Access
  • Meeting abstract

Rocío Brom-Valladares, Mario Patiño-Zarco, Rita Sotelo-Regil, José Chanona-Vilchis, Margarita Ibarra

Management of post-radiotherapy hemorrhagic cystitis refractory to conventional treatment

  • Open Access
  • Meeting abstract

Ricardo Perez-Mendoza, Pedro Martinez, Mario Solares, Marco Badillo, Mauricio Gallo, Miguel A Jiménez-Rios

Retroperitoneal soft tissue sarcoma

  • Open Access
  • Meeting abstract

Ernesto Zepeda, Mario Cuellar Hubbé, Héctor Martínez Saíd, Alejandro Padilla-Rosciano, Carolina Gutiérrez

Germ-cell tumors with sarcomatous components. A clinicopathologic and immunohistochemical study of 48 cases

  • Open Access
  • Meeting abstract

Hugo Dominguez-Malagon, Ana Maria Cano-Valdez, Ana Graciela Puebla-Mora, Cesar A Moran, Saul Suster

Management of osteosarcomas over one decade: the INCAN experience

  • Open Access
  • Meeting abstract

Mario Cuellar Hubbë, Ernesto Zepeda Castilla, Carolina Gutiérrez, Silvia Marmolejo, Héctor Martínez Saíd, Myrna Durán, Alejandro Padilla-Rosciano

Skin-sparing mastectomy in breast cancer

  • Open Access
  • Meeting abstract

Patricia Villarreal-Colin, Carlos Robles-Vidal, Monica Drucker-Zertuche

Who are the best candidates for multiorgan resection among patients with T4 gastric carcinoma?

  • Open Access
  • Meeting abstract

Luis F Oñate-Ocaña, Mauricio Becker, Vincenzo Aiello-Crocifoglio, Dolores Gallardo-Rincón, Rocío Brom-Valladares, Roberto Herrera-Goepfert, José F Carrillo, Arturo Beltrán-Ortega

Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy

  • Open Access
  • Meeting abstract

Heidy Cedeño, Rafael Araúz, Fernando Cebamanos, Idalmis de Torraza, Ana Porcell

GIST in a reference cancer center in México

  • Open Access
  • Meeting abstract

Horacio Noe López-Basave, Flavia Morales-Vázquez, Esmeralda Patricia Ochoa, Juan Manuel Ruiz-Molina, German Calderillo-Ruiz

Neu im Fachgebiet Onkologie

Pflanzenbasierte Kost und Krebsrisiko

Eine gepoolte Analyse von elf prospektiven Studien liefert eine umfassende Bestandsaufnahme zu Zusammenhängen von verschiedenen Kostformen und dem Krebsrisiko. Neben bekannten Vorteilen von eher pflanzenbasierten Kostformen fanden sich überraschenderweise auch Hinweise auf einzelne ungünstige Effekte.   

Erhöhtes Krebsrisiko unter Erythropoese-Stimulation

Hohe Wochendosierungen Erythropoese-stimulierender Substanzen erhöhen möglicherweise das Krebsrisiko von Dialysekranken: In einer Analyse aus Korea traten neue Tumorerkrankungen bei hohen Dosierungen um etwa ein Viertel häufiger auf.

Lässt sich Menstruationsblut für die Krebsfrüherkennung nutzen?

Ergebnisse einer Studie aus China legen nahe: Ein an Menstruationsblut durchgeführter HPV-Test schneidet in puncto Dysplasie-Detektion ähnlich gut ab wie eine übliche HPV-Untersuchung per Abstrich. An weiterer Diagnostik mittels Periodenblut wird gearbeitet. Ein Überblick.

Oligometastasiertes Mammakarzinom: Was bringen invasive Lokaltherapien?

Falls invasive lokalregionale Maßnahmen bei einem neudiagnostizierten oligometastasierten Mammakarzinom erwogen werden, könnte es prognostisch womöglich günstig sein, (auch) den Primarius zu resezieren. Dafür spricht zumindest eine retrospektive Kohortenstudie aus den USA. Allerdings bleiben viele Fragen offen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Seniorenpaar frühstückt/© Halfpoint / stock.adobe.com (Symbolbild mit Fotomodellen), Dialyse/© Semen Salivanychuk / stock.adobe.com (Symbolbild mit Fotomodell), Rack mit Blutproben/© James Thew / Stock.adobe.com